Forest Labs Subpoenaed Over Hypertension Meds

Law360, New York (May 9, 2011, 8:19 PM EDT) -- Forest Laboratories Inc. said Monday it had received a subpoena from the U.S. attorney's office in Massachusetts seeking information related to hypertension treatment medications.

U.S. Attorney Carmen Ortiz’s office sent an April 20 subpoena to the New York-based company with requests to turn over documents involving its Benicar, Benicar HCT and Azor drugs, Forest said in a statement. Forest and Benicar’s originator, Daiichi Sankyo Inc., co-marketed the drug from 2002 through 2008.

“The company intends to cooperate in responding to the subpoena,” Forest said.

Forest’s announcement...
To view the full article, register now.